Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Hazard Ratio01:12

Hazard Ratio

91
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
91
Relative Risk01:12

Relative Risk

122
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
122
Hazard Rate01:11

Hazard Rate

91
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
91
Cancer Survival Analysis01:21

Cancer Survival Analysis

328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

99
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
99
Actuarial Approach01:20

Actuarial Approach

63
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
63

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Future worldwide coronavirus disease 2019 epidemic predictions by Gaidai multivariate risk evaluation method.

Analytical science advances·2024
Same author

Gaidai reliability method for long-term coronavirus modelling.

F1000Research·2023
Same author

Prediction of death rates for cardiovascular diseases and cancers.

Cancer innovation·2023
Same author

Carbon Storage Tanker Lifetime Assessment.

Global challenges (Hoboken, NJ)·2023
Same author

Meta-Structure Hull Design with Periodic Layered Phononic Crystals Theory for Wide-Band Low-Frequency Sound Insolation.

Materials (Basel, Switzerland)·2023
Same author

Multi-regional COVID-19 epidemic forecast in Sweden.

Digital health·2023

相关实验视频

Updated: Jun 10, 2025

Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach
07:06

Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach

Published on: December 1, 2011

13.3K

根据Gaidai的多变量风险评估方法预测艾滋病毒死亡率.

Oleg Gaidai1

  • 1Department of Mechanics and Mathematics, Ivan Franko Lviv State University, Lviv, Ukraine.

Immunity, inflammation and disease
|October 16, 2024
PubMed
概括

这项研究引入了一种新的生物统计方法,以评估全球人类免疫缺陷病毒 (HIV) 死亡风险. 该方法为公共卫生规划提供可靠的长期艾滋病毒死亡率评估.

科学领域:

  • 公共卫生 公共卫生
  • 生物统计学 生物统计学
  • 流行病学 流行病学

背景情况:

  • 人类免疫缺陷病毒 (HIV) 由于其高传染性和死亡率,对全球公共卫生构成了重大挑战.
  • 评估艾滋病毒死亡风险的现有方法经常与复杂的,高维度的跨国数据集作斗争.

研究的目的:

  • 开发和应用一种新的多变量生物风险评估方法来确定过度的艾滋病毒死亡风险.
  • 为了能够在不同地区进行可靠的长期艾滋病死亡率评估.

主要方法:

  • 开发了一种新的基于人口的,多中心的,基于医学调查的生物统计方法.
  • 这项研究将Gaidai新的方法应用于原始,未经过的临床数据集,解决两种和高维极值统计的挑战.

主要成果:

  • 成功地应用了新的生物风险评估方法.
  • 实现了可靠的长期艾滋病毒死亡风险评估.

结论:

  • 拟议的方法为公共卫生和临床应用提供了一个强大的工具.
  • 这种方法可以利用现有的原始患者调查数据集来改进风险评估.
关键词:
在这里,我们可以看到AIAIAI.艾滋病 艾滋病 艾滋病是什么?艾滋病病毒 艾滋病病毒 艾滋病病毒这一流行性疫情爆发.数学生物学 数学生物学公共卫生 公共卫生

更多相关视频

Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses
11:19

Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses

Published on: May 4, 2015

11.1K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K

相关实验视频

Last Updated: Jun 10, 2025

Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach
07:06

Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach

Published on: December 1, 2011

13.3K
Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses
11:19

Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses

Published on: May 4, 2015

11.1K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K